Arriving in the arena of obesity therapy, retatrutide is a distinct approach. Beyond many existing medications, retatrutide functions as a double agonist, simultaneously engaging both GLP-like peptide-1 (GLP-1) and https://arrancgxr759612.targetblogs.com/39037611/the-novel-retatrutide-a-glp-and-gip-binding-site-agonist